BRIEF published on 03/10/2025 at 15:34, 10 months 19 days ago Goldman Sachs reduces its stake in EUROAPI Euronext Paris Participation Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 02/14/2025 at 12:20, 11 months 15 days ago Goldman Sachs Crosses Threshold in EUROAPI Acquisition Goldman Sachs Crossing Thresholds Shares And Voting Rights EUROAPI
BRIEF published on 02/11/2025 at 14:00, 11 months 18 days ago Goldman Sachs reduces its stake in EUROAPI Stock Market Goldman Sachs Threshold Crossing Transfer Of Shares EUROAPI
BRIEF published on 01/31/2025 at 14:28, 11 months 29 days ago Threshold Crossings by The Goldman Sachs Group, Inc. at EUROAPI Actions Financial Market Goldman Sachs Crossing Thresholds EUROAPI
BRIEF published on 12/09/2024 at 20:22, 1 year 1 month ago EUROAPI Enters a New Chapter with Leadership Changes Pharmaceuticals 2024 Outlook Leadership Change EUROAPI FOCUS-27 Plan
PRESS RELEASE published on 12/09/2024 at 20:17, 1 year 1 month ago EUROAPI moves into a new chapter with new Governance and Leadership EUROAPI enters a new chapter with new Governance and Leadership as Emmanuel Blin becomes Independent Chair of the Board and David Seignolle appointed Chief Executive Officer, maintaining full-year 2024 guidance Governance Leadership EUROAPI Emmanuel Blin David Seignolle
BRIEF published on 10/16/2024 at 07:05, 1 year 3 months ago Appointment of Olivier Falut as Financial Director of EUROAPI Appointment Financial Director EUROAPI Olivier Falut FOCUS-27 Transformation
PRESS RELEASE published on 10/16/2024 at 07:00, 1 year 3 months ago Olivier Falut appointed EUROAPI’s Chief Financial Officer Olivier Falut appointed EUROAPI's Chief Financial Officer. He brings 30 years of financial management experience in the industrial sector. EUROAPI focuses on innovative active ingredient solutions for global health Chief Financial Officer Industrial Sector EUROAPI Active Ingredient Solutions Olivier Falut
BRIEF published on 10/10/2024 at 20:43, 1 year 3 months ago EUROAPI secures financing for its FOCUS-27 plan Funding Sanofi EUROAPI Hybrid Bond FOCUS-27 Plan
PRESS RELEASE published on 10/10/2024 at 20:38, 1 year 3 months ago EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution EUROAPI completes financing of FOCUS-27 plan, refinancing €451M Credit Facility & issuing €200M Hybrid Bond, enhancing collaboration with Sanofi Financing Partnership Sanofi EUROAPI FOCUS-27
Published on 01/30/2026 at 02:15, 5 hours 1 minute ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 7 hours 16 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 8 hours 16 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 12 hours 31 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 13 hours 16 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/30/2026 at 07:00, 16 minutes ago Unbroken record series with high revenue momentum for cloud and subscriptions – 20th record year in a row for revenue and earnings
Published on 01/30/2026 at 04:30, 2 hours 46 minutes ago A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 3 hours 41 minutes ago Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 7 hours 8 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 10 hours 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 18:00, 13 hours 16 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 13 hours 31 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 13 hours 31 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 10:07, 21 hours 8 minutes ago Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech
